Efficacy of nirmatrelvir and ritonavir for post‐acute COVID‐19 sequelae beyond 3 months of SARS‐CoV‐2 infection

MH Chuang, JY Wu, TH Liu, WH Hsu… - Journal of Medical …, 2023 - Wiley Online Library
The effect of nirmatrelvir plus ritonavir (NMV‐r) on post‐acute COVID‐19 sequelae beyond 3
months of SARS‐CoV‐2 infection remains unknown. This retrospective cohort study utilized …

Efficacy of nirmatrelvir and ritonavir for post-acute COVID-19 sequelae beyond 3 months of SARS-CoV-2 infection.

MH Chuang, JY Wu, TH Liu, WH Hsu… - Journal of Medical …, 2023 - europepmc.org
The effect of nirmatrelvir plus ritonavir (NMV-r) on post-acute COVID-19 sequelae beyond 3
months of SARS-CoV-2 infection remains unknown. This retrospective cohort study utilized …

Efficacy of nirmatrelvir and ritonavir for post-acute COVID-19 sequelae beyond 3 months of SARS-CoV-2 infection

MH Chuang, JY Wu, TH Liu, WH Hsu… - Journal of medical …, 2023 - pubmed.ncbi.nlm.nih.gov
The effect of nirmatrelvir plus ritonavir (NMV-r) on post-acute COVID-19 sequelae beyond 3
months of SARS-CoV-2 infection remains unknown. This retrospective cohort study utilized …